Organometallics
Article
TP: Typical Procedure for the Direct Ortho Acetoxylation of
Ar-O-DMT Ethers. A solution of Ar-−O-DMT ether (1 mmol),
Pd(OAc) (11 mg, 0.05 mmol), and PhI(OAc) (644 mg, 2 mmol) in
2-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-5-ethylphenyl Acetate
(3g). According to TP, 2-(4-ethylphenoxy)-4,6-dimethoxy-1,3,5-
triazine (261 mg, 1 mmol) gave the desired product 3g (152 mg,
2
2
1
AcOH (4.0 mL) and Ac O (4.0 mL) was stirred in a 25 mL Schlenk
48%) as a colorless oil. H NMR (400 MHz, CDCl ): δ (ppm) 7.14−
2
3
tube at 100 °C for 24 h. The solvent was evaporated to dryness in
vacuo. The residue was purified by column chromatography
7.10 (m, 1 H), 7.06−6.99 (m, 2 H), 3.93 (s, 6 H), 2.62 (q, J = 7.6 Hz,
2 H), 2.12 (s, 3 H), 1.210 (t, J = 7.6 Hz, 3 H). 13C NMR (100 MHz,
(
petroleum ether/ethyl acetate) to give the desired product.
-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-3,5-dimethylphenyl Ac-
etate (3a). According to TP, 2-(2,4-dimethylphenoxy)-4,6-dimethoxy-
CDCl ): δ (ppm) 173.8, 172.9, 168.3, 143.0, 141.8, 140.8, 125.9,
3
2
122.8, 122.7, 55.5, 28.2, 20.7, 15.0. IR (KBr): 3248, 2965, 1775, 1567,
−1
1506, 1470, 1362, 1266, 1212, 1189, 1129, 935, 820 cm . HRMS
+
1
6
,3,5-triazine (261 mg, 1 mmol) gave the desired product 3a (217 mg,
(C H N O + H): calcd, 320.1246; found, 320.1248 (M + H).
15
17
3
5
1
8%) as a white solid (mp 78.2−79.5 °C). H NMR (400 MHz,
5-(tert-Butyl)-2-((4,6-dimethoxy-1,3,5-triazin-2-yl)oxy)phenyl Ac-
etate (3h). According to TP, 2-(4-(tert-butyl)phenoxy)-4,6-dime-
CDCl ): δ (ppm) 6.91 (s, 1 H), 6.83 (s, 1 H), 3.96 (s, 6 H), 2.30 (s, 3
H), 2.15 (s, 3 H), 2.12 (s, 3 H). C NMR (100 MHz, CDCl ): δ
3
13
thoxy-1,3,5-triazine (289 mg, 1 mmol) gave the desired product 3h
3
1
(
ppm) 173.9, 172.8, 168.5, 141.9, 139.6, 136.2, 131.5, 128.9, 121.4,
(205 mg, 59%) as a pale yellow oil. H NMR (400 MHz, CDCl ): δ
3
5
1
5.5, 20.9, 20.7, 16.1. IR (KBr): 3129, 1766, 1568, 1400, 1357, 1216,
(ppm) 7.30−7.26 (m, 1 H), 7.21−7.17 (m, 2 H), 3.99 (s, 6 H), 2.18
−1
13
122, 816, 693 cm . HRMS (C H N O + H): calcd, 320.1246;
(s, 3 H), 1.32 (s, 9 H). C NMR (100 MHz, CDCl ): δ (ppm) 173.7,
15
17
3
5
3
+
found, 320.1246 (M + H).
172.8, 168.2, 149.9, 141.4, 140.5, 123.4, 122.3, 120.5, 55.4, 34.5, 31.2,
−1
2
-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-3,5-dineopentylphenyl
20.6. IR (KBr): 3129, 1775, 1562, 1400, 1208, 1180, 817 cm . HRMS
+
Acetate (3b). According to TP, 2-(2,4-dineopentylphenoxy)-4,6-
dimethoxy-1,3,5-triazine (373 mg, 1 mmol) gave the desired product
3
(C H N O + H): calcd, 348.1559; found, 348.1562 (M + H).
17
21
3
5
2-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-5-methoxyphenyl Ace-
tate (3i). According to TP, 2,4-dimethoxy-6-(4-methoxyphenoxy)-
1
b (256 mg, 59%) as a colorless oil. H NMR (400 MHz, CDCl ): δ
3
(
ppm) 7.12 (d, J = 2.2 Hz, 1 H), 6.98 (d, J = 2.2 Hz, 1 H), 3.90 (s, 6
1,3,5-triazine (263 mg, 1 mmol) gave the desired product 3i (158 mg,
1
H), 1.97 (s, 3 H), 1.59 (dt, J = 14.6 Hz, 7.3 Hz, 4 H), 1.28 (s, 6 H),
1
52%) as a pale yellow oil. H NMR (400 MHz, CDCl ): δ (ppm) 7.16
3
13
.25 (s, 6 H), 1.59 (ddd, J = 16.0 Hz, 7.5 Hz, 7.3 Hz, 6 H). C NMR
(d, J = 8.8 Hz, 1 H), 6.82−6.75 (m, 2 H), 3.98 (s, 6 H), 3.80 (s, 3 H),
2.17 (s, 3 H). 13C NMR (100 MHz, CDCl ): δ (ppm) 173.8, 173.2,
(
100 MHz, CDCl ): δ (ppm) 173.8, 173.0, 167.9, 146.6, 142.2, 139.8,
3
3
1
8
9
4
39.6, 123.1, 118.9, 55.4, 38.8, 37.9, 36.9, 34.6, 28.3, 28.2, 20.6, 9.3,
.9. IR (KBr): 3129, 1768, 1596, 1558, 1400, 1367, 1230, 1200, 1137,
168.1, 157.7, 142.6, 136.7, 123.4, 111.8, 109.2, 55.7, 55.5, 20.7. IR
(KBr): 3373, 2952, 1774, 1571, 1505, 1470, 1364, 1210, 1124, 819
−
1
−1
77, 816 cm . HRMS (C H N O + H): calcd, 432.2498; found,
cm . HRMS (C14
H
15
N
3
O
6
+ H): calcd, 322.1039; found, 322.1037
23
33
3
5
+
+
32.2502 (M + H).
-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-3-methoxy-5-methyl-
phenyl Acetate (3c). According to TP, 2,4-dimethoxy-6-(2-methoxy-
-methylphenoxy)-1,3,5-triazine (275 mg, 1 mmol) gave the desired
product 3c (158 mg, 47%) as a pale yellow solid (mp 124.5−125.7
(M + H).
2
2-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-4,6-dimethylphenyl Ac-
etate (3j). According to TP, 2-(3,5-dimethylphenoxy)-4,6-dimethoxy-
1,3,5-triazine (261 mg, 1 mmol) gave the desired product 3j (114 mg,
4
1
36%) as a white solid (mp 101.5−102.3 °C). H NMR (400 MHz,
1
°
C). H NMR (400 MHz, CDCl ): δ (ppm) 6.63 (d, J = 1.2 Hz, 1 H),
CDCl ): δ (ppm) 6.93 (s, 1 H), 6.88 (s, 1 H), 3.98 (s, 6 H), 2.30 (s, 3
3
3
13
6
2
1
.58 (d, J = 1.2 Hz, 1 H), 3.93 (s, 6 H), 3.73 (s, 3 H), 2.31 (s, 3 H),
H), 2.18 (s, 3 H), 2.15 (s, 3 H). C NMR (100 MHz, CDCl ): δ
3
.14 (s, 3 H). 13C NMR (100 MHz, CDCl ): δ (ppm) 173.7, 172.8,
(ppm) 173.8, 173.0, 168.2, 143.1, 138.7, 136.2, 131.9, 129.2, 121.0,
3
68.3, 151.8, 142.8, 136.4, 130.5, 115.6, 110.7, 56.1, 55.3, 21.5, 20.6. IR
55.5, 20.9, 20.3, 16.2. IR (KBr): 3130, 1759, 1571, 1400, 1360, 1315,
−1
−1
(
KBr): 3130, 1766, 1585, 1400, 1369, 1216, 1192, 1101, 819 cm .
1189, 1145, 901, 853, 819 cm . HRMS (C15
H
17
N
3
O
5
+ H): calcd,
+
+
HRMS (C H N O + H): calcd, 336.1196; found, 336.1192 (M +
320.1246; found, 320.1248 (M + H).
15
17
3
6
H).
2-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)phenyl Acetate (3k). Ac-
3
-(tert-Butyl)-2-((4,6-dimethoxy-1,3,5-triazin-2-yl)oxy)phenyl Ac-
cording to TP, 2,4-dimethoxy-6-phenoxy-1,3,5-triazine (233 mg, 1
etate (3d). According to TP, 2-(2-(tert-butyl)phenoxy)-4,6-dime-
mmol) gave the desired product 3k (154 mg, 53%) as a white solid
1
thoxy-1,3,5-triazine (289 mg, 1 mmol) gave the desired product 3d
149 mg, 43%) as a pale yellow oil. H NMR (400 MHz, CDCl ): δ
(mp 49.7−51.5 °C). H NMR (400 MHz, CDCl ): δ (ppm) 7.31−
3
1
13
(
7.21 (m, 4 H), 3.98 (s, 6 H), 2.18 (s, 3 H). C NMR (100 MHz,
3
(
ppm) 7.32−7.28 (m, 1 H), 7.21 (t, J = 8.1 Hz, 1 H), 7.10 (dd, J = 7.9
CDCl ): δ (ppm) 173.8, 172.8, 168.2, 143.1, 142.2, 126.7, 126.5,
3
13
Hz, 1.6 Hz, 1 H), 3.96 (s, 6 H), 2.03 (s, 3 H), 1.34 (s, 9 H). C NMR
123.6, 123.2, 55.5, 20.6. IR (KBr): 3129, 1772, 1573, 1400, 1247, 1208,
−
1
(
100 MHz, CDCl ): δ (ppm) 173.7, 172.9, 167.9, 142.9, 142.7, 142.0,
1120, 938, 911, 820 cm . HRMS (C H N O + H): calcd,
3
13 13 3 5
+
1
1
25.6, 124.2, 121.2, 55.4, 34.8, 30.2, 20.5. IR (KBr): 3457, 1775, 1587,
292.0933; found, 292.0934 (M + H).
−1
560, 1469, 1357, 1203, 1122, 820 cm . HRMS (C H N O + H):
5-Chloro-2-((4,6-dimethoxy-1,3,5-triazin-2-yl)oxy)-4-ethylphenyl
Acetate (3l). According to TP, 2-(4-chloro-3-ethylphenoxy)-4,6-
dimethoxy-1,3,5-triazine (296 mg, 1 mmol) gave the desired product
17
21
3
5
+
calcd, 348.1559; found, 348.1559 (M + H).
-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-4-methoxyphenyl Ace-
tate (3e). According to TP, 2,4-dimethoxy-6-(3-methoxyphenoxy)-
2
1
3l (138 mg, 39%) as a pale yellow solid (mp 49.1−50.4 °C). H NMR
1
3
7
,3,5-triazine (526 mg, 2 mmol) gave the desired product 3e (199 mg,
(400 MHz, CDCl ): δ (ppm) 7.22 (s, 1 H), 7.11 (s, 1 H), 3.96 (s, 6
3
1
1%) as a colorless oil. H NMR (400 MHz, CDCl ): δ (ppm) 7.12−
H), 2.71 (q, J = 7.5 Hz, 2 H), 2.13 (s, 3 H), 1.21 (t, J = 7.5 Hz, 3 H).
3
13
.07 (m, 1 H), 6.80−6.75 (m, 2 H), 3.96 (s, 6 H), 3.76 (s, 3 H), 2.11
C NMR (100 MHz, CDCl ): δ (ppm) 173.8, 172.7, 167.9, 141.7,
3
(
s, 3 H). 13C NMR (100 MHz, CDCl ): δ (ppm) 173.8, 172.8, 168.5,
140.3, 140.2, 130.9, 124.4, 123.3, 55.6, 26.3, 20.6, 13.6. IR (KBr):
3
−1
1
2
57.7, 143.5, 135.8, 123.8, 111.9, 108.8, 55.7, 55.5, 20.5. IR (KBr):
952, 1768, 1588, 1568, 1505, 1471, 1362, 1202, 1124, 1031, 819
3129, 1777, 1591, 1400, 1200, 1153, 1020, 901, 813 cm . HRMS
+
(C H ClN O + H): calcd, 354.0857; found, 354.0855 (M + H).
15
16
3
5
−
1
cm . HRMS (C H N O + H): calcd, 322.1039; found, 322.1037
5-Bromo-2-((4,6-dimethoxy-1,3,5-triazin-2-yl)oxy)phenyl Acetate
(3m). According to TP, 2-(4-bromophenoxy)-4,6-dimethoxy-1,3,5-
14
15
3
6
+
(
M + H).
-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-5-methylphenyl Ace-
tate (3f). According to TP, 2,4-dimethoxy-6-(p-tolyloxy)-1,3,5-triazine
247 mg, 1 mmol) gave the desired product 3f (151 mg, 49%) as a
2
triazine (312 mg, 1 mmol) gave the desired product 3m (94 mg, 25%)
1
as a yellow oil. H NMR (400 MHz, CDCl ): δ (ppm) 7.40−7.36 (m,
3
1
3
(
2 H), 7.15−7.09 (m, 1 H), 3.97 (s, 6 H), 2.15 (s, 3 H). C NMR (100
MHz, CDCl ): δ (ppm) 173.8, 172.6, 167.7, 142.8, 142.4, 129.6, 127.0,
1
white solid (mp 81.5−82.3 °C). H NMR (400 MHz, CDCl ): δ
3
3
(
(
ppm) 7.14−7.10 (m, 1 H), 7.07−7.00 (m, 2 H), 3.96 (s, 6 H), 2.35
124.5, 118.9, 55.6, 20.6. IR (KBr): 3105, 2952, 1780, 1594, 1575, 1471,
s, 3 H), 2.15 (s, 3 H). 13C NMR (100 MHz, CDCl ): δ (ppm) 173.8,
−1
3
1362, 1265, 1201, 1123, 1011, 921, 819 cm . HRMS (C H BrN O
13 12
3
5
+
1
72.9, 168.4, 141.7, 140.7, 136.9, 127.2, 124.1, 122.7, 55.5, 20.9, 20.7.
+ H): calcd, 370.0039; found, 370.0040 (M + H).
−1
IR (KBr): 3129, 1767, 1586, 1552, 1400, 1216, 1136, 1022, 820 cm .
HRMS (C H N O + H): calcd, 306.1090; found, 306.1092 (M +
H).
2-((4,6-Dimethoxy-1,3,5-triazin-2-yl)oxy)-5-fluorophenyl Acetate
(3n). According to TP, 2-(4-fluorophenoxy)-4,6-dimethoxy-1,3,5-
triazine (251 mg, 1 mmol) gave the desired product 3n (65 mg,
+
14
15
3
5
D
Organometallics XXXX, XXX, XXX−XXX